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BRIEF REPORT
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Abstract	
There is growing recognition of the importance of engaging patients early in the design of research
studies. For studies involving patients with intellectual and cognitive disabilities, researchers may
consider engaging with family caregivers, health professionals, community advocates, and/or subject
matter experts to provide a more multifaceted, surrogate perspective. Evaluating the engagement of
these stakeholder groups in research is nascent, and tools are limited. Research studies involving these
individuals provide the opportunity to test new methods of measurement of stakeholder engagement
in research. We conducted a 3-year research study implementing and evaluating Down Syndrome
Clinic to You, an online platform for caregivers of individuals with Down syndrome who do not have
access to Down syndrome specialists. We established 3 key stakeholder groups — family caregivers,
primary care physicians, and medical/scientific experts in the field — who were involved from grantwriting through preparation of the final report. To assess stakeholder engagement, we utilized the
Patient Engagement in Research Scale, a validated instrument originally developed to evaluate patient
engagement in arthritis research. Overall, results were suggestive of strong engagement levels by the
key stakeholder groups. This study contributes to the limited available literature evaluating measures
of stakeholder engagement in research. (J Patient Cent Res Rev. 2021;8:64-67.)
Keywords	stakeholder engagement; Patient Engagement in Research Scale; PEIRS; participatory research;
Down syndrome; cognitive disability

P

atients who participate in hands-on, decisionmaking, and advisory activities at any stage of
the research process — outside of their roles as
study participants — are helping to fill an important gap
in clinical research. By bringing their lived experiences
while research teams craft study procedures and
dissemination plans, patients have the potential to enrich
the relevance, practical feasibility, and, ultimately, impact
of the research being conducted.1-3 For patients who
are children, or who have an intellectual or cognitive
disability that may prevent their full participation as
advisors, adopting a more holistic viewpoint on who
may participate on their behalf may be considered. The
inclusion of family caregivers, health professionals,
community advocates, and/or subject matter experts all
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can provide important feedback on what is important to
patients who are less able to communicate their needs,
values, and preferences.3
Our research team recently conducted a national
randomized controlled trial of an online health care
platform for caregivers of individuals with Down
syndrome, a genetic condition oftentimes accompanied
by complex co-occurring medical conditions.4 With
this platform, called Down Syndrome Clinic to You
(DSC2U), family caregivers complete a comprehensive,
online intake form and then receive an automatically
generated checklist of personalized recommendations
with a companion plan to share with the primary care
provider. DSC2U was found to be effective in improving
adherence to the national Down syndrome health care
guidelines.4 As patients with Down syndrome all have
mild to severe intellectual disabilities, the DSC2U
intervention was developed for use by their concerned
caregivers. We relied on these advocates to best inform
our research on DSC2U, engaging key stakeholder
groups (family caregivers, primary care physicians, and
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subject matter experts) over a 3-year period in the design,
conduct, implementation, and dissemination of that
randomized controlled trial.
However, a nominal inclusion of these patient
representatives does not necessarily translate into
meaningful engagement. At the conclusion of the
trial, we wanted to evaluate, in some objective way,
whether the engagement of those key stakeholders
was truly meaningful. The development of methods to
measure stakeholder engagement in research is at an
early stage. Studies targeting specific patient-centered
outcomes developed in partnership with patients or their
caregiver representatives, such as ours, can be testbeds
for the application of new methods of measurement of
stakeholder engagement in research.
In this paper, we evaluate stakeholder engagement using
the Patient Engagement in Research Scale (PEIRS), a
validated instrument originally developed to evaluate
patient stakeholder engagement in arthritis research.1 We
sought to extend this body of literature to a novel set of
patient representatives.

METHODS

Description of Stakeholder Involvement

We established 3 working groups to support our study.
The Caregiver Working Group consisted of 7 individuals
from across the United States — mothers who had sons
or daughters with Down syndrome and/or leaders of
Down syndrome nonprofit organizations. The Primary
Care Physician Working Group consisted of 4 physicians
located in Massachusetts, Oregon, and New Hampshire,
each with 1 to 5 patients with Down syndrome in their
practices. The Expert Working Group consisted of 5
physicians and scientists with expertise in developmental
pediatrics, mental health wellness in teens and adults,
informed medical decision-making, genetics, and
internal medicine.
Each stakeholder group met separately for an hour every
month by teleconference, led by representatives from the
core research team, including the principal investigator
(PI) and research assistant. Other core research team
members attended periodically to discuss key documents
such as consent information, survey questions, website
copy, or clinical algorithms. These discussion-format
meetings began from the inception of grant writing in
August 2015 and continued through the completion of the
study in August 2019. Before these meetings, working
group members received a detailed agenda, distributed by
Google Docs, which provided access to real-time sharing.
Following each meeting, the research assistant sent out
detailed meeting notes via the same mechanism.
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Working group members were engaged with every
phase of the study and offered feedback on all aspects
of the DSC2U intervention, including design of the
informational project website, the content of the online
intake, and the algorithms behind the customizable
content that would be shared with caregivers and primary
care providers. Stakeholders also refined study outcomes,
brainstormed recruitment strategies, and reviewed
interim and final data analyses. Toward the end of the
trial, working groups also were particularly instructive
in strategies to disseminate the findings within the Down
syndrome community.
Participants

All members of the 3 working groups were invited to
participate in the PEIRS survey evaluation. To provide
a benchmark, the core research team comprising 8
researchers from Massachusetts General Hospital
(Boston, MA) who were primarily responsible for the
creation of DSC2U also were surveyed. This team
included physicians, software engineers, statisticians,
survey methodologists, and research assistants.
Survey Instrument

PEIRS is a framework designed by Hamilton et al at the
University of British Columbia (Vancouver, Canada).1
It was developed, with content and face validation,
to quantifiably assess meaningful patient engagement
throughout the research process from the patient
perspective. The PEIRS survey includes 37 questions,
each using a 5-point Likert rating scale, organized
across 7 conceptual themes: procedural requirements,
convenience, contributions, team environment, support,
research environment, feeling valued, and benefits.1
For this study, the PEIRS survey was used in its entirety,
with only slight wording changes to address questions
to our 3 working group members instead of patients.
The core research team (described in detail under
“Participants”) reviewed the PEIRS and felt that face
validity was appropriate for our purposes. To give our
participants the opportunity to share feedback that may
not have been covered by the PEIRS, our questionnaire
concluded with 2 additional open-ended questions:
•
“Thinking about your experience working on the
DSC2U project, what do you believe were its most
important areas of strength?”
•
“Thinking about your experience working on the
DSC2U project, what were areas that could have used
some improvement?”
The original PEIRS was self-administered on paper at a
stakeholder meeting; we administered our questionnaire
electronically at the conclusion of the 3-year study
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period using REDCap (Research Electronic Data
Capture) electronic data capture tools hosted at Partners
HealthCare (Boston, MA).5,6 REDCap is a secure,
web-based software platform designed to support data
capture for research studies. All 23 members across the 4
groups received an initial invitation by email and up to 3
reminders by email. Responses were anonymous.
Analysis

The PEIRS scoring guide was used to calculate the total
score.1 Each item was first converted from its 5-point
Likert scale descriptive category (strongly agree to
strongly disagree) to a numerical score. The sum of scores
across all 7 themes was calculated for each respondent,
then divided by the total maximum score of 148 and
multiplied by 100 to calculate a PEIRS total score.

RESULTS

Of the 23 persons invited to participate during the period
from June to July 2019, 22 (95.7%) completed the survey
across the 3 categories of stakeholders (ie, caregivers,
primary care physicians, and expert advisors) and the
core research team members. The average total score
on the PEIRS instrument was 93.5 out of a maximum
of 100 (Table 1). Experts ranked their experience in the
DSC2U research process the most favorably (PEIRS total
score: 97.8); primary care physicians had the lowest score
(PEIRS total score: 86.7).
Respondents identified project strengths in verbatim
response questions, which included the effective
leadership of the PI: “[He] brought a great team of
researchers and parents together to create a tool that
is useful and beneficial to the community.” and “The
objective behind it was such a good one, it was hard
not to be excited to be a part of it. The meetings were
well organized and efficient and [the PI] is so incredibly
positive that it is contagious.”

Table 1. Mean PEIRS Total Scores by Stakeholder
Group, Overall
Stakeholder group

n

Mean PEIRS
total score

Core research team
Expert advisors
Caregivers
Primary care physicians

8
3
7
4

94.9
97.8
94.6
86.7

Overall

22

93.5

PEIRS, Patient Engagement in Research Scale.
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Respondents also commented about the organization
of the project: “The project was a very collaborative
process. Attention to detail also a strength.” and “Clear,
concise communication. Strong respectful team with
dedication to the project and purpose.”
Respondents were asked to identify areas for
improvement. A few stakeholders in the external groups
noted that it might have been productive to have meetings
clustered around the needs of the project rather than at
predetermined intervals. Given the amount of work in the
initial phases, some stakeholders suggested that having
more frequent meetings early in the project would have
been beneficial. Others commented that there could have
been less frequent meetings once the study was underway,
especially during the randomized controlled trial period
when the project was running smoothly.

DISCUSSION

The PEIRS total scores varied slightly among the 4
groups of respondents but were all suggestive of strong
engagement levels by key stakeholders. However, the
PEIRS survey does not yet offer a way of understanding
how to interpret these total scores and subgroup
differences. That primary care physicians scored lower
than the other groups has some face validity, as Down
syndrome care and research influences their professional
and personal lives the least, particularly when compared
to families of a loved one with Down syndrome or
community advocates and research experts who have
built their professions around Down syndrome.
There is growing literature advocating for greater
engagement of patients and caregivers in research
as well as expanding efforts by sponsors to ensure
stakeholder engagement.cf.7 Even among individuals
with intellectual disability,8 including those with Down
syndrome,9 researchers are thinking of creative ways to
engage these groups at different stages in the research
process to mutual benefit. A recently published report
on stakeholder experience also noted the unexpected
therapeutic benefit of engaging in patient-centered
research.10 There are, however, few studies that evaluate
any measures of engagement, one of the first steps in
understanding its value and building an evidence base for
its practice.cf.11 Given the current climate of encouraging
patient and stakeholder participation in publicly funded
research, we were surprised to find relatively few reports
of stakeholder experience in the literature.
We did not re-validate the PEIRS for our mixedstakeholder participant group; if we had done so, this
group of stakeholders might have identified additional
important measures to include. Also, administering this
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survey at the conclusion of the study period rather than
at regularly scheduled intervals made it impossible to act
on recommended changes and thwarted any opportunity
to see if and how engagement might have evolved.
Nevertheless, the survey proved a useful way to engage
stakeholders in a final step of assessing our research
process and outcomes.
In summary, this study demonstrated that an assessment
of stakeholder involvement in research for people with
intellectual disabilities is possible and warranted.
In summary, this study demonstrated that an assessment
Recap in research for people with
ofPatient-Friendly
stakeholder involvement
intellectual
disabilities
is possible
andpush
warranted.
• Contemporary

research
standards
for
obtaining patient input on study design and
execution. However, this may be unrealistic when
the targeted population has an intellectual disability.
• In
 a randomized controlled trial for patients with
Down syndrome, authors collaborated with various
surrogates (family caregivers, primary physicians,
Down syndrome experts) in lieu of patient
engagement.
• After the trial’s conclusion, participating
stakeholders were surveyed regarding their
involvement in the research project.
• High

scores of engagement were reported by all
stakeholder groups, suggesting this type of patientoriented research may be achievable when direct
patient involvement is not.
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